Acotec Scientific Holdings Ltd
HKEX:6669

Watchlist Manager
Acotec Scientific Holdings Ltd Logo
Acotec Scientific Holdings Ltd
HKEX:6669
Watchlist
Price: 12.72 HKD -3.2% Market Closed
Market Cap: HK$4B

Net Margin

17%
Current
Improving
by 7.2%
vs 3-y average of 9.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
17%
=
Net Income
¥100.9m
/
Revenue
¥592.9m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
17%
=
Net Income
HK$100.9m
/
Revenue
¥592.9m

Peer Comparison

Country Company Market Cap Net
Margin
CN
Acotec Scientific Holdings Ltd
HKEX:6669
4B HKD
Loading...
US
Abbott Laboratories
NYSE:ABT
201.9B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
178.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
148B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
125B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
113.6B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.8B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
52.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
50.3B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
50.3B USD
Loading...
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.3B USD
Loading...

Market Distribution

Higher than 85% of companies in China
Percentile
85th
Based on 8 721 companies
85th percentile
17%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Acotec Scientific Holdings Ltd
Glance View

Market Cap
4B HKD
Industry
Health Care

Acotec Scientific Holdings Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-08-24. The firm focuses on interventional treatment of vascular diseases, involving Drug-coated Balloons (DCB) and Percutaneous Transluminal Angioplasty Balloon Catheter (PTA) etc. The firm has established a product portfolio for five major therapeutic areas, including vascular surgery, cardiology, nephrology, neurology and andrology. The firm's business covers China, Asia, Europe and other countries and regions.

Acotec Scientific Holdings Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
17%
=
Net Income
¥100.9m
/
Revenue
¥592.9m
What is Acotec Scientific Holdings Ltd's current Net Margin?

The current Net Margin for Acotec Scientific Holdings Ltd is 17%, which is above its 3-year median of 9.9%.

How has Net Margin changed over time?

Over the last 3 years, Acotec Scientific Holdings Ltd’s Net Margin has increased from -10% to 17%. During this period, it reached a low of -10% on Jun 30, 2022 and a high of 17.7% on Dec 31, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett